The cumulative influenza-associated hospitalization rate for the 2024 to 2025 season surpassed all end-of-season rates during the period beginning with the 2010 to 2011 season, according to research published in the U.S. ...
Sep 17, 2025
0
13
TherVacB, a therapeutic vaccine for chronic hepatitis B, has entered its first clinical trial in patients. The first patient was enrolled in June 2025 and treated with the vaccine. In a previous trial in healthy volunteers, ...
Jul 24, 2025
0
34
Feline infectious peritonitis, or FIP, is a serious and historically fatal disease in cats caused by a coronavirus. It behaves in many ways like severe coronavirus infections in humans, causing widespread inflammation, T ...
Jul 14, 2025
0
323
Mpox has the potential to become a significant global health threat if taken too lightly, according to scientists at the University of Surrey.
Apr 1, 2025
0
37
A team of Yale School of Medicine infectious diseases researchers recently conducted an in-depth review of the literature on how one genus of viruses, known as flaviviruses, manipulates mitochondria to evade immune responses. ...
Feb 26, 2025
0
27
Highly pathogenic H5N1 avian influenza A virus (HPAI H5N1) remains a low risk to the general public, and public health experts in the United States believe that available treatments and vaccines, as well as those in development, ...
Jan 2, 2025
0
21
Scientists at the University of Helsinki, University of Eastern Finland and University of Turku are investigating the intricate ways in which various SARS-CoV-2 variants, like delta and omicron, interact with human cells ...
Dec 10, 2024
0
43
Researchers at The Jackson Laboratory and Trudeau Institute have identified the first mouse strain that is susceptible to severe COVID-19 without the need for genetic modification. This development, reported in Scientific ...
Dec 6, 2024
0
108
Starting antiviral treatment as late as 14 days after infection with SARS-CoV-2 may still be beneficial in hosts with compromised immune systems, who are at greatest risk of developing severe COVID-19, according to researchers ...
Sep 3, 2024
0
30
While the World Health Organization declares mpox a global emergency based on rapid spread in African countries, the infectious disease formerly known as monkeypox has been considered an epidemic in the U.S. since 2022.
Aug 27, 2024
1
32
